This is the authors' abstract. We don't add key points for this paper.
Herein, we describe the design, synthesis and biological evaluation of a series of novel non-nucleotide sulfonylurea and sulfonylthiourea based small molecule inhibitors of h-ENPP1, h-ENPP3 and e5′NT. Among the tested compounds, 3b inhibited h-ENPP1 with an IC50 value of 0.11 ± 0.01 µM. Similarly, 4b was found to be the most potent inhibitor tested against h-ENPP3 with an IC50 value of 0.038 ± 0.02 µM. Compound 3a revealed remarkable inhibitory potency against human ecto-5′-nucleotidase with an IC50 value of 0.83 ± 0.01 µM while compound 3b possessed IC50 value of 0.26 ± 0.05 µM against rat ecto-5′-nucleotidase. Antiproliferative activity of novel sulfonylurea and sulfonylthiourea derivatives was investigated on breast cancer cell line (MCF-7). Compound 4a showed anticancer activity against MCF-7 cell line with percentage inhibition of 64 and successfully arrested the viability of cancer cells. The compounds were not cytotoxic to the normal cells derived from baby hamster kidney (BHK-21).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Alzahrani et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: